• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Port Info

• Ships in Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• The Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

P. T. Jyothi Datta

Mumbai , April 18

CHARAK Pharma has entered into an alliance with Russian allopathic company Avin Pharma to co-market its liver disorder drug Livomin. Next on the anvil is the anti-diabetic drug, Hyponidd, currently under registration in the Russian market.

"Registration is a process in itself, taking about two years and about $40,000," Mr Pulin Shroff, Managing Director of Charak Pharma, told Business Line.

Exports are projected to touch Rs 20 crore on revenues of Rs 140 crore by March 2006, he said. The company closed the year ended March 2005 at Rs 110 crore, with exports of Rs 11 crore.

On the domestic front, the company has recently launched its Phytonova division to focus on muscular skeletal disease, skin disorders and cardiac-related problems. As part of this initiative, the company has already launched an anti-arthritis, rheumatoid and asthma medicines. To support this initiative, the company has also got on board a field-force of about 110 people across the country. Mr Shroff expects the new division to clock about Rs 10 crore in its first year of operation.

The next therapeutic segment that the company is looking at is skin disorders for which clinical studies are being done at JJ Hospital, he said.

Calling for a separate division to support the new products, he said that the company's existing field-force is focused on gynaecology and gastro-related segments. Doctor-detailing is being done afresh by the new field-force. A few existing brands with Charak that have a synergy with the new division have been re-jigged to give the new branch a basket of products that the field-force can take to doctors, he added.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Glenmark floats unit to reach out to doctors

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line